Project Details
| Status | Active |
|---|---|
| Effective start/end date | 1/04/18 → 31/12/25 |
Funding
- EUROPEAN COMMISSION: £2,446,029.22
Clinical development of a therapeutic vaccine for prevention of post kala azar dermal leishmaniasis
- Kaye, Paul (Principal investigator)
- Lacey, Charles John Nash (Co-investigator)
Project: Research project (funded) › Research